ARTEMISMED

Artemis Medicare Services Financial Results

₹318.70+0.11%
Market cap
₹15,000 crore
P/E
22.5
P/B
3.20
ROE
11.4%
Dividend yield
0.14%

For the year ended Mar 2020, Artemis Medicare Services reported revenue of ₹565 crore and net profit of ₹19 crore, against ₹408 crore and ₹6 crore a year earlier.

Artemis Medicare Services annual profit and loss

Financial years, newest first. TTM = trailing twelve months.

Artemis Medicare Services annual profit and loss (₹ crore)
ItemMar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Revenue565408555737879922
Expenses504373487643746768
Operating profit61356794133154
Operating margin %11%9%12%13%15%17%
Other income5747723
Interest131312203133
Depreciation232222314044
Profit before tax31837516899
Tax %36%18%16%25%28%26%
Net profit19631384974
EPS (₹)——————
Dividend payout %——————

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Artemis Medicare Services financial results — frequently asked questions

What is Artemis Medicare Services' annual revenue and net profit?

For the financial year ended Mar 2020, Artemis Medicare Services' revenue was ₹565 crore and net profit ₹19 crore; net profit rose 216.67% from ₹6 crore in Mar 2021.

How fast has Artemis Medicare Services grown over three years?

From Mar 2023 to Mar 2020, Artemis Medicare Services' revenue grew at a compound annual rate of -8.5% and net profit at -20.6%. Past growth does not indicate future results.

Are these figures consolidated or standalone?

They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.

Same Data For Peers

Trade Artemis Medicare Services With ATS

Track ARTEMISMED live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.